Skip to content
10-K

Annual Report

Protagonist Therapeutics, Inc PTGX

0001558370-25-001317

← back to feed
Filed
Feb 21, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 19, 2025 61.38M sh
Current Liabilities FY 2024 · Dec 31, 2023 $21.27M
Total Liabilities FY 2024 · Dec 31, 2023 $21.27M
Current Assets FY 2024 · Dec 31, 2023 $355.58M
Total Assets FY 2024 · Dec 31, 2023 $357.95M
Shares Diluted FY 2024 · Dec 31, 2022 49.04M sh
Capex FY 2024 · Dec 31, 2022 $795K
Operating Cash Flow FY 2024 · Dec 31, 2022 −$108.14M
Cash And Equivalents FY 2024 · Dec 31, 2022 $125.74M
Eps Diluted FY 2024 · Dec 31, 2022 −$2.60
Eps Basic FY 2024 · Dec 31, 2022 −$2.60
Sga Expense FY 2024 · Dec 31, 2022 $31.74M
Rd Expense FY 2024 · Dec 31, 2022 $126.22M
Net Income FY 2024 · Dec 31, 2022 −$127.39M
Operating Income FY 2024 · Dec 31, 2022 −$131.37M
Stockholders Equity FY 2024 · Dec 31, 2021 $300.02M